These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16713718)

  • 41. Effects of somatostatin on glucagon-stimulated glycogenolysis and gluconeogenesis in hepatocytes cultured in vitro.
    Rosa J; Rosa J; Fister V
    Acta Physiol Scand; 1992 Oct; 146(2):205-11. PubMed ID: 1359734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin inhibits glucagon-induced glycogenolysis normally in perivenous hepatocytes of Wistar fatty rats.
    Ikezawa Y; Yamatani K; Ohnuma H; Daimon M; Manaka H; Sasaki H
    Diabetes Res Clin Pract; 2005 Aug; 69(2):120-3. PubMed ID: 16005360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effect of [Asu1 . 7]-eel calcitonin on glucagon-induced glycogenolysis in perfused rat liver.
    Mine T; Kimura S; Ogata E
    Horm Metab Res; 1983 Mar; 15(3):139-43. PubMed ID: 6303930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site.
    Praly JP; Vidal S
    Mini Rev Med Chem; 2010 Oct; 10(12):1102-26. PubMed ID: 20716051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of celiac superior mesenteric ganglionectomy on glucose homeostasis and hormonal changes during oral glucose tolerance testing in rats.
    Kumakura A; Shikuma J; Ogihara N; Eiki J; Kanazawa M; Notoya Y; Kikuchi M; Odawara M
    Endocr J; 2013; 60(4):525-31. PubMed ID: 23318598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y; Donahue EP; Shiota M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats.
    Burkey BF; Li X; Bolognese L; Balkan B; Mone M; Russell M; Hughes TE; Wang PR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):688-95. PubMed ID: 16027230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial.
    Dirnena-Fusini I; Åm MK; Fougner AL; Carlsen SM; Christiansen SC
    BMJ Open Diabetes Res Care; 2018; 6(1):e000560. PubMed ID: 30487972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The time course of myocardial glycogenolysis stimulated by glucagon.
    Laughlin MR; Petit WA; Barrett EJ
    J Mol Cell Cardiol; 1993 Feb; 25(2):175-83. PubMed ID: 8474125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
    Baker DJ; Timmons JA; Greenhaff PL
    Diabetes; 2005 Aug; 54(8):2453-9. PubMed ID: 16046314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.
    Greene HL; Wilson FA; Hefferan P; Terry AB; Moran JR; Slonim AE; Claus TH; Burr IM
    J Clin Invest; 1978 Aug; 62(2):321-8. PubMed ID: 276529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lactate produced by glycogenolysis in astrocytes regulates memory processing.
    Newman LA; Korol DL; Gold PE
    PLoS One; 2011; 6(12):e28427. PubMed ID: 22180782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inadequate brain glycogen or sleep increases spreading depression susceptibility.
    Kilic K; Karatas H; Dönmez-Demir B; Eren-Kocak E; Gursoy-Ozdemir Y; Can A; Petit JM; Magistretti PJ; Dalkara T
    Ann Neurol; 2018 Jan; 83(1):61-73. PubMed ID: 29244233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels.
    Åm MK; Dirnena-Fusini I; Fougner AL; Carlsen SM; Christiansen SC
    Sci Rep; 2020 Aug; 10(1):13735. PubMed ID: 32792580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of hepatic nerve stimulation on blood glucose and glycogenolysis in rat liver: studies with in vivo microdialysis.
    Takahashi A; Ishimaru H; Ikarashi Y; Kishi E; Maruyama Y
    J Auton Nerv Syst; 1996 Nov; 61(2):181-5. PubMed ID: 8946339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-linear mixed effects modeling of sparse concentration data from rats: application to a glycogen phosphorylase inhibitor.
    Ingwersen SH; Kiehr B; Iversen L; Andersen MP; Petersen Y; Rytved KA
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):203-12. PubMed ID: 12365203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model.
    Teigen IA; Åm MK; Carlsen SM; Christiansen SC
    Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):623-631. PubMed ID: 35416407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of glycogenolysis towards antidiabetic and other therapies.
    Somsák L
    Mini Rev Med Chem; 2010 Oct; 10(12):1091-2. PubMed ID: 20716057
    [No Abstract]   [Full Text] [Related]  

  • 60. Glucagon administration to the rat via eye drops.
    Pillion DJ; McCracken DL; Yang M; Atchison JA
    J Ocul Pharmacol; 1992; 8(4):349-58. PubMed ID: 1484265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.